fate1 targeted shrnas Search Results


fate1 targeted shrnas  (Addgene inc)
91
Addgene inc fate1 targeted shrnas
Fig. 1: <t>FATE1</t> is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607
Fate1 Targeted Shrnas, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fate1+targeted+shrnas/pmyc-GFP-TNRC6A-(1027-1076)+(Plasmid+%2342019)/10__1128_slash_mcb__00138___19-175-12-56
Average 91 stars, based on 1 article reviews
fate1 targeted shrnas - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
plko  (Addgene inc)
93
Addgene inc plko
Fig. 1: <t>FATE1</t> is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607
Plko, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fate1+targeted+shrnas/pLKO%2E1+luciferase+shRNA+(Plasmid+%2330324)/pmc06597881-387-30-37
Average 93 stars, based on 1 article reviews
plko - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
nontargeting shrna  (Addgene inc)
93
Addgene inc nontargeting shrna
Fig. 1: <t>FATE1</t> is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607
Nontargeting Shrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fate1+targeted+shrnas/Lentiviral+nontargeting+shRNA+GFP+(Plasmid+%23155285)/pmc06597881-387-27-37
Average 93 stars, based on 1 article reviews
nontargeting shrna - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 1: FATE1 is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607

Journal: Molecular and Cellular Biology

Article Title: EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival

doi: 10.1128/mcb.00138-19

Figure Lengend Snippet: Fig. 1: FATE1 is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607

Article Snippet: For shRNA experiments pLKO.1 vectors from The RNA 312 Consortium (TRC) expressing FATE1 targeted shRNAs (A7: TRCN0000130192 and A9: 313 on M ay 4, 2019 by guest http://m cb.asm .org/ D ow nloaded from 12 TRCN0000146597) were obtained from the UNC Lentiviral core and a non-targeting shRNA in pLKO.1 314 (shSCR) was used as a control (Addgene).

Techniques:

Fig. 5: FATE1 Destabilizes BNIP3L. (A, B) 72 hours after siRNA transfection, WCLs were collected 655

Journal: Molecular and Cellular Biology

Article Title: EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival

doi: 10.1128/mcb.00138-19

Figure Lengend Snippet: Fig. 5: FATE1 Destabilizes BNIP3L. (A, B) 72 hours after siRNA transfection, WCLs were collected 655

Article Snippet: For shRNA experiments pLKO.1 vectors from The RNA 312 Consortium (TRC) expressing FATE1 targeted shRNAs (A7: TRCN0000130192 and A9: 313 on M ay 4, 2019 by guest http://m cb.asm .org/ D ow nloaded from 12 TRCN0000146597) were obtained from the UNC Lentiviral core and a non-targeting shRNA in pLKO.1 314 (shSCR) was used as a control (Addgene).

Techniques: Transfection